Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Sensory sensitivity and symptom severity represent unique dimensions of chronic pain: a MAPP Research Network study.

Schrepf A, Williams DA, Gallop R, Naliboff BD, Basu N, Kaplan C, Harper DE, Landis JR, Clemens JQ, Strachan E, Griffith JW, Afari N, Hassett A, Pontari MA, Clauw DJ, Harte SE; MAPP Research Network.

Pain. 2018 Oct;159(10):2002-2011. doi: 10.1097/j.pain.0000000000001299.

PMID:
29863527
2.

Correlates of Health Care Seeking Activities in Patients with Urological Chronic Pelvic Pain Syndromes: Findings from the MAPP Cohort.

Clemens JQ, Stephens-Shields A, Naliboff BD, Lai HH, Rodriguez L, Krieger JN, Williams DA, Kusek JW, Landis JR; MAPP Research Network.

J Urol. 2018 Jul;200(1):136-140. doi: 10.1016/j.juro.2017.12.055. Epub 2018 Jan 4.

3.

A Case-Crossover Study of Urological Chronic Pelvic Pain Syndrome Flare Triggers in the MAPP Research Network.

Sutcliffe S, Jemielita T, Lai HH, Andriole GL, Bradley CS, Clemens JQ, Gallop R, Hooton TM, Kreder KJ, Krieger JN, Kusek JW, Labus J, Lucia MS, Mackey S, Naliboff BD, Robinson NA, Rodriguez LV, Stephens-Shields A, van Bokhoven A, Wolin KY, Yan Y, Yang CC, Landis JR, Colditz GA; MAPP Research Network.

J Urol. 2018 May;199(5):1245-1251. doi: 10.1016/j.juro.2017.12.050. Epub 2017 Dec 27.

PMID:
29288643
4.

Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response.

Park SH, Naliboff BD, Shih W, Presson AP, Videlock EJ, Ju T, Kilpatrick L, Gupta A, Mayer EA, Chang L.

Neurogastroenterol Motil. 2018 Jan;30(1). doi: 10.1111/nmo.13155. Epub 2017 Jul 18.

PMID:
28718999
5.

Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network.

Naliboff BD, Stephens AJ, Lai HH, Griffith JW, Clemens JQ, Lutgendorf S, Rodriguez LV, Newcomb C, Sutcliffe S, Guo W, Kusek JW, Landis JR; MAPP Research Network.

J Urol. 2017 Oct;198(4):848-857. doi: 10.1016/j.juro.2017.05.065. Epub 2017 May 18.

PMID:
28528930
6.

Gene expression profiles in peripheral blood mononuclear cells correlate with salience network activity in chronic visceral pain: A pilot study.

Gupta A, Cole S, Labus JS, Joshi S, Nguyen TJ, Kilpatrick LA, Tillisch K, Naliboff BD, Chang L, Mayer EA.

Neurogastroenterol Motil. 2017 Jun;29(6). doi: 10.1111/nmo.13027. Epub 2017 Feb 12.

7.

Sex-based differences in brain alterations across chronic pain conditions.

Gupta A, Mayer EA, Fling C, Labus JS, Naliboff BD, Hong JY, Kilpatrick LA.

J Neurosci Res. 2017 Jan 2;95(1-2):604-616. doi: 10.1002/jnr.23856. Review.

8.

Biopsychosocial Aspects of Functional Gastrointestinal Disorders.

Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, Murphy TB, Naliboff BD, Levy RL.

Gastroenterology. 2016 Feb 18. pii: S0016-5085(16)00218-3. doi: 10.1053/j.gastro.2016.02.027. [Epub ahead of print]

PMID:
27144624
9.

Relationships of abdominal pain, reports to visceral and temperature pain sensitivity, conditioned pain modulation, and heart rate variability in irritable bowel syndrome.

Jarrett ME, Han CJ, Cain KC, Burr RL, Shulman RJ, Barney PG, Naliboff BD, Zia J, Heitkemper MM.

Neurogastroenterol Motil. 2016 Jul;28(7):1094-103. doi: 10.1111/nmo.12812. Epub 2016 Mar 19.

10.

Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research Network.

Griffith JW, Stephens-Shields AJ, Hou X, Naliboff BD, Pontari M, Edwards TC, Williams DA, Clemens JQ, Afari N, Tu F, Lloyd RB, Patrick DL, Mullins C, Kusek JW, Sutcliffe S, Hong BA, Lai HH, Krieger JN, Bradley CS, Kim J, Landis JR.

J Urol. 2016 Apr;195(4 Pt 1):949-54. doi: 10.1016/j.juro.2015.11.012. Epub 2015 Nov 14.

11.

Unique Microstructural Changes in the Brain Associated with Urological Chronic Pelvic Pain Syndrome (UCPPS) Revealed by Diffusion Tensor MRI, Super-Resolution Track Density Imaging, and Statistical Parameter Mapping: A MAPP Network Neuroimaging Study.

Woodworth D, Mayer E, Leu K, Ashe-McNalley C, Naliboff BD, Labus JS, Tillisch K, Kutch JJ, Farmer MA, Apkarian AV, Johnson KA, Mackey SC, Ness TJ, Landis JR, Deutsch G, Harris RE, Clauw DJ, Mullins C, Ellingson BM; MAPP Research Network.

PLoS One. 2015 Oct 13;10(10):e0140250. doi: 10.1371/journal.pone.0140250. eCollection 2015.

12.

Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel Syndrome.

Jarrett ME, Cain KC, Barney PG, Burr RL, Naliboff BD, Shulman R, Zia J, Heitkemper MM.

J Neurogastroenterol Motil. 2016 Jan 31;22(1):102-11. doi: 10.5056/jnm15067.

13.

Sex commonalities and differences in the relationship between resilient personality and the intrinsic connectivity of the salience and default mode networks.

Kilpatrick LA, Istrin JJ, Gupta A, Naliboff BD, Tillisch K, Labus JS, Mayer EA.

Biol Psychol. 2015 Dec;112:107-15. doi: 10.1016/j.biopsycho.2015.09.010. Epub 2015 Oct 9.

14.

Widespread Psychosocial Difficulties in Men and Women With Urologic Chronic Pelvic Pain Syndromes: Case-control Findings From the Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network.

Naliboff BD, Stephens AJ, Afari N, Lai H, Krieger JN, Hong B, Lutgendorf S, Strachan E, Williams D; MAPP Research Network.

Urology. 2015 Jun;85(6):1319-27. doi: 10.1016/j.urology.2015.02.047.

15.

Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome.

Hubbard CS, Hong J, Jiang Z, Ebrat B, Suyenobu B, Smith S, Heendeniya N, Naliboff BD, Tillisch K, Mayer EA, Labus JS.

Neurogastroenterol Motil. 2015 Sep;27(9):1282-94. doi: 10.1111/nmo.12622. Epub 2015 Jun 19.

16.

Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study.

Shahabi L, Naliboff BD, Shapiro D.

Psychol Health Med. 2016;21(2):176-88. doi: 10.1080/13548506.2015.1051557. Epub 2015 Jun 18.

PMID:
26086986
17.

The MAPP research network: design, patient characterization and operations.

Landis JR, Williams DA, Lucia MS, Clauw DJ, Naliboff BD, Robinson NA, van Bokhoven A, Sutcliffe S, Schaeffer AJ, Rodriguez LV, Mayer EA, Lai HH, Krieger JN, Kreder KJ, Afari N, Andriole GL, Bradley CS, Griffith JW, Klumpp DJ, Hong BA, Lutgendorf SK, Buchwald D, Yang CC, Mackey S, Pontari MA, Hanno P, Kusek JW, Mullins C, Clemens JQ; MAPP Research Network Study Group.

BMC Urol. 2014 Aug 1;14:58. doi: 10.1186/1471-2490-14-58.

18.

Widespread hyperalgesia in adolescents with symptoms of irritable bowel syndrome: results from a large population-based study.

Stabell N, Stubhaug A, Flægstad T, Mayer E, Naliboff BD, Nielsen CS.

J Pain. 2014 Sep;15(9):898-906. doi: 10.1016/j.jpain.2014.05.007. Epub 2014 Jun 4.

PMID:
24905280
19.

Alterations in resting state oscillations and connectivity in sensory and motor networks in women with interstitial cystitis/painful bladder syndrome.

Kilpatrick LA, Kutch JJ, Tillisch K, Naliboff BD, Labus JS, Jiang Z, Farmer MA, Apkarian AV, Mackey S, Martucci KT, Clauw DJ, Harris RE, Deutsch G, Ness TJ, Yang CC, Maravilla K, Mullins C, Mayer EA.

J Urol. 2014 Sep;192(3):947-55. doi: 10.1016/j.juro.2014.03.093. Epub 2014 Mar 26.

20.

Gastrointestinal specific anxiety in irritable bowel syndrome: validation of the Japanese version of the visceral sensitivity index for university students.

Saigo T, Tayama J, Hamaguchi T, Nakaya N, Tomiie T, Bernick PJ, Kanazawa M, Labus JS, Naliboff BD, Shirabe S, Fukudo S.

Biopsychosoc Med. 2014 Mar 21;8(1):10. doi: 10.1186/1751-0759-8-10.

21.

Synergistic application of cardiac sympathetic decentralization and comprehensive psychiatric treatment in the management of anxiety and electrical storm.

Khalsa SS, Shahabi L, Ajijola OA, Bystritsky A, Naliboff BD, Shivkumar K.

Front Integr Neurosci. 2014 Jan 2;7:98. doi: 10.3389/fnint.2013.00098. eCollection 2014.

22.

Stress reactivity in traditional Chinese medicine-based subgroups of patients with irritable bowel syndrome.

Chang MC, Shapiro D, Joshi A, Shahabi L, Tan S, Smith S, Hui KK, Tillisch K, Mayer EA, Naliboff BD.

J Altern Complement Med. 2014 Apr;20(4):276-83. doi: 10.1089/acm.2013.0197. Epub 2013 Nov 20.

23.

Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.

Labus JS, Hubbard CS, Bueller J, Ebrat B, Tillisch K, Chen M, Stains J, Dukes GE, Kelleher DL, Naliboff BD, Fanselow M, Mayer EA.

Gastroenterology. 2013 Dec;145(6):1253-61.e1-3. doi: 10.1053/j.gastro.2013.08.016. Epub 2013 Aug 14. Review.

24.

Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease.

Cheng P, Shih W, Alberto M, Presson AP, Licudine A, Mayer EA, Naliboff BD, Chang L.

Neurogastroenterol Motil. 2013 Oct;25(10):e650-9. doi: 10.1111/nmo.12177. Epub 2013 Jul 3.

25.

Heart rate variability as a biomarker for autonomic nervous system response differences between children with chronic pain and healthy control children.

Evans S, Seidman LC, Tsao JC, Lung KC, Zeltzer LK, Naliboff BD.

J Pain Res. 2013 Jun 12;6:449-57. doi: 10.2147/JPR.S43849. Print 2013.

26.

Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome.

Ellingson BM, Mayer E, Harris RJ, Ashe-McNally C, Naliboff BD, Labus JS, Tillisch K.

Pain. 2013 Sep;154(9):1528-41. doi: 10.1016/j.pain.2013.04.010. Epub 2013 Apr 8.

27.

Conditioned pain modulation in children and adolescents: effects of sex and age.

Tsao JC, Seidman LC, Evans S, Lung KC, Zeltzer LK, Naliboff BD.

J Pain. 2013 Jun;14(6):558-67. doi: 10.1016/j.jpain.2013.01.010. Epub 2013 Mar 27.

28.

Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N, Firth R, Sitrin MD, Katz L, Krasner SS, Ballou SK, Naliboff BD, Mayer EA.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1147-57. doi: 10.1016/j.cgh.2013.03.011. Epub 2013 Mar 21.

29.

Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.

Labus J, Gupta A, Gill HK, Posserud I, Mayer M, Raeen H, Bolus R, Simren M, Naliboff BD, Mayer EA.

Aliment Pharmacol Ther. 2013 Feb;37(3):304-15. doi: 10.1111/apt.12171. Epub 2012 Dec 3.

30.

Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome.

Berman S, Suyenobu B, Naliboff BD, Bueller J, Stains J, Wong H, Mandelkern M, Fitzgerald L, Ohning G, Gupta A, Labus JS, Tillisch K, Mayer EA.

Neuroimage. 2012 Dec;63(4):1854-63. doi: 10.1016/j.neuroimage.2012.08.028. Epub 2012 Aug 21.

31.

Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome.

Wolitzky-Taylor K, Craske MG, Labus JS, Mayer EA, Naliboff BD.

Behav Res Ther. 2012 Oct;50(10):647-50. doi: 10.1016/j.brat.2012.05.010. Epub 2012 Jun 23.

32.

Human anterior and posterior hippocampus respond distinctly to state and trait anxiety.

Satpute AB, Mumford JA, Naliboff BD, Poldrack RA.

Emotion. 2012 Feb;12(1):58-68. doi: 10.1037/a0026517.

PMID:
22309734
33.

Association between early adverse life events and irritable bowel syndrome.

Bradford K, Shih W, Videlock EJ, Presson AP, Naliboff BD, Mayer EA, Chang L.

Clin Gastroenterol Hepatol. 2012 Apr;10(4):385-90.e1-3. doi: 10.1016/j.cgh.2011.12.018. Epub 2011 Dec 16.

34.

Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis.

Naliboff BD, Kim SE, Bolus R, Bernstein CN, Mayer EA, Chang L.

Am J Gastroenterol. 2012 Mar;107(3):451-9. doi: 10.1038/ajg.2011.377. Epub 2011 Nov 15.

35.

Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.

Hubbard CS, Labus JS, Bueller J, Stains J, Suyenobu B, Dukes GE, Kelleher DL, Tillisch K, Naliboff BD, Mayer EA.

J Neurosci. 2011 Aug 31;31(35):12491-500. doi: 10.1523/JNEUROSCI.1860-11.2011.

36.

Attachment figures activate a safety signal-related neural region and reduce pain experience.

Eisenberger NI, Master SL, Inagaki TK, Taylor SE, Shirinyan D, Lieberman MD, Naliboff BD.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11721-6. doi: 10.1073/pnas.1108239108. Epub 2011 Jun 27.

37.

A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations.

Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, Naliboff BD.

Behav Res Ther. 2011 Jun;49(6-7):413-21. doi: 10.1016/j.brat.2011.04.001. Epub 2011 Apr 19.

38.

Modulation of nociceptive and acoustic startle responses to an unpredictable threat in men and women.

Hubbard CS, Ornitz E, Gaspar JX, Smith S, Amin J, Labus JS, Kilpatrick LA, Rhudy JL, Mayer EA, Naliboff BD.

Pain. 2011 Jul;152(7):1632-40. doi: 10.1016/j.pain.2011.03.001. Epub 2011 Apr 8.

39.

Impact of Mindfulness-Based Stress Reduction training on intrinsic brain connectivity.

Kilpatrick LA, Suyenobu BY, Smith SR, Bueller JA, Goodman T, Creswell JD, Tillisch K, Mayer EA, Naliboff BD.

Neuroimage. 2011 May 1;56(1):290-8. doi: 10.1016/j.neuroimage.2011.02.034. Epub 2011 Feb 18.

40.

A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.

Naliboff BD, Wu SM, Schieffer B, Bolus R, Pham Q, Baria A, Aragaki D, Van Vort W, Davis F, Shekelle P.

J Pain. 2011 Feb;12(2):288-96. doi: 10.1016/j.jpain.2010.09.003. Epub 2010 Nov 26.

PMID:
21111684
41.

Gating of sensory information differs in patients with interstitial cystitis/painful bladder syndrome.

Kilpatrick LA, Ornitz E, Ibrahimovic H, Hubbard CS, Rodríguez LV, Mayer EA, Naliboff BD.

J Urol. 2010 Sep;184(3):958-63. doi: 10.1016/j.juro.2010.04.083.

42.

Regional gray matter density changes in brains of patients with irritable bowel syndrome.

Seminowicz DA, Labus JS, Bueller JA, Tillisch K, Naliboff BD, Bushnell MC, Mayer EA.

Gastroenterology. 2010 Jul;139(1):48-57.e2. doi: 10.1053/j.gastro.2010.03.049. Epub 2010 Mar 27.

43.

Sex-related differences in prepulse inhibition of startle in irritable bowel syndrome (IBS).

Kilpatrick LA, Ornitz E, Ibrahimovic H, Treanor M, Craske M, Nazarian M, Labus JS, Mayer EA, Naliboff BD.

Biol Psychol. 2010 May;84(2):272-8. doi: 10.1016/j.biopsycho.2010.02.012. Epub 2010 Mar 1.

44.

A picture's worth: partner photographs reduce experimentally induced pain.

Master SL, Eisenberger NI, Taylor SE, Naliboff BD, Shirinyan D, Lieberman MD.

Psychol Sci. 2009 Nov;20(11):1316-8. doi: 10.1111/j.1467-9280.2009.02444.x. Epub 2009 Sep 24. No abstract available.

PMID:
19788531
45.

Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome.

Labus JS, Naliboff BD, Berman SM, Suyenobu B, Vianna EP, Tillisch K, Mayer EA.

Neuroimage. 2009 Sep;47(3):952-60. doi: 10.1016/j.neuroimage.2009.05.078. Epub 2009 Jun 6.

46.

Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat.

Twiss C, Kilpatrick L, Craske M, Buffington CA, Ornitz E, Rodríguez LV, Mayer EA, Naliboff BD.

J Urol. 2009 May;181(5):2127-33. doi: 10.1016/j.juro.2009.01.025. Epub 2009 Mar 14.

47.

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study.

Jarcho JM, Chang L, Berman M, Suyenobu B, Naliboff BD, Lieberman MD, Ameen VZ, Mandelkern MA, Mayer EA.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):344-52.

48.

Increased acoustic startle responses in IBS patients during abdominal and nonabdominal threat.

Naliboff BD, Waters AM, Labus JS, Kilpatrick L, Craske MG, Chang L, Negoro H, Ibrahimovic H, Mayer EA, Ornitz E.

Psychosom Med. 2008 Oct;70(8):920-7. doi: 10.1097/PSY.0b013e318186d858. Epub 2008 Oct 8.

49.

Developmental changes in startle reactivity in school-age children at risk for and with actual anxiety disorder.

Waters AM, Craske MG, Bergman RL, Naliboff BD, Negoro H, Ornitz EM.

Int J Psychophysiol. 2008 Dec;70(3):158-64. doi: 10.1016/j.ijpsycho.2008.07.014. Epub 2008 Jul 28.

PMID:
18718853
50.

Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.

Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, Ameen VZ, Mayer EA.

Neurogastroenterol Motil. 2009 Feb;21(2):149-59. doi: 10.1111/j.1365-2982.2008.01171.x. Epub 2008 Aug 5.

Supplemental Content

Loading ...
Support Center